SEC Form D · filed December 8, 2022
Karyopharm Therapeutics Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (28)
Mansoor R. Mirza · Newton, MADirectorPeter G. Honig · Newton, MADirectorMichael Mano · Newton, MAExecMichael Mason · TORONTO, Ontario, CanadaExecDeepika R. Pakianathan · Newton, MADirectorChen R. Schor · Newton, MADirectorBarry E. Greene · Newton, MADirectorRichard Paulson · Newton, MAExec · DirectorGaren G. Bohlin · Newton, MADirectorMansoor R. Mirza · Newton, MADirectorChristy J. Oliger · Newton, MADirectorMichael Mano · Newton, MAExecChristy J. Oliger · Newton, MADirectorBarry E. Greene · Newton, MADirectorStephen Mitchener · Newton, MAExecChen R. Schor · Newton, MADirectorGaren G. Bohlin · Newton, MADirectorSohanya Cheng · Newton, MAExecMichael Mason · Marina Del Rey, CAExecPeter G. Honig · Newton, MADirectorReshma Rangwala · Newton, MAExecSohanya Cheng · Newton, MAExecDeepika R. Pakianathan · Newton, MADirectorStephen Mitchener · Newton, MAExecStuart Poulton · Newton, MAExecRichard Paulson · Newton, MAExec · DirectorStuart Poulton · Newton, MAExecReshma Rangwala · Newton, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗